Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

DSpace Repository

Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

Author: Niessner, Heike; Kosnopfel, Corinna; Sinnberg, Tobias; Beck, Daniela; Krieg, Kathrin; Wanke, Ines; Lasithiotakis, Konstantinos; Bonin, Michael; Garbe, Claus; Meier, Friedegund
Tübinger Autor(en):
Niessner, Heike
Kosnopfel, Corinna
Sinnberg, Tobias
Beck, Daniela
Krieg, Kathrin
Wanke, Ines
Lasithiotakis, Konstantinos
Bonin, Michael
Garbe, Claus
Meier, Friedegund
Published in: Experimental Dermatology (2017), Bd. 26, H. SI, S. 598-606
Verlagsangabe: Wiley
Language: English
Full text: http://dx.doi.org/10.1111/exd.13372
ISSN: 1600-0625
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)